Wed, April 12, 2017

by: WOPRAI

GME, EPD, APU, MMP, VO, OKE Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

VTR, PAA, IXC, IJH, OZRK, LYG Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

IJJ, NFX, PXD, TOO, RF, SNHY Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

URTY, QQEW, ALLT, PYZ, HF, CLR Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

PZN, VBR, VB, IGE, TNA, TRGP Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

KNDI, QNST, PRMW, ACH, PGX, SUMR Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

PCLN, HZO, MMM Expected To Be Up Before Next Earnings Releases

by: WOPRAI

Pedro Leduc Upgraded (CCU) to Hold on, Apr 12th, 2017

by: WOPRAI

Kevin DeGeeter Initiated (CDTX) at Strong Buy and Held Target at $225 on, Apr 12th, 2017

by: WOPRAI

Chris Olin Initiated (X) at Hold on, Apr 12th, 2017

by: WOPRAI

Michael Wood Initiated (TILE) at Strong Buy and Held Target at $22 on, Apr 12th, 2017

by: WOPRAI

Richard Bove Downgraded (WFC) to Strong Sell and Decreased Target to $55 on, Apr 12th, 2017

by: WOPRAI

Steven Lichtman Downgraded (AVGR) to Hold on, Apr 12th, 2017

by: WOPRAI

Michael Wood Initiated (AWI) at Strong Buy and Held Target at $55 on, Apr 12th, 2017

by: WOPRAI

Matt Sheerin Upgraded (SNX) to Strong Buy and Held Target at $120 on, Apr 12th, 2017

by: WOPRAI

Derek Archila Initiated (VNDA) at Buy on, Apr 12th, 2017

by: WOPRAI

Walter Pritchard Upgraded (VRSN) to Hold on, Apr 12th, 2017

by: WOPRAI

Michael Wood Initiated (SWK) at Strong Buy and Held Target at $145 on, Apr 12th, 2017

by: WOPRAI

Christopher Horvers Downgraded (TSCO) to Hold on, Apr 12th, 2017

by: WOPRAI

Michael Wood Initiated (BLD) at Hold and Held Target at $45 on, Apr 12th, 2017

by: WOPRAI

Tom Roderick Initiated (ADBE) at Strong Buy and Held Target at $150 on, Apr 12th, 2017

by: WOPRAI

Paul Morgan Reiterated (AAT) at Strong Buy with Increased Target to $50 on, Apr 12th, 2017

by: WOPRAI

Robert Lee Upgraded (AB) to Buy and Held Target at $26 on, Apr 12th, 2017

by: WOPRAI

Michael Derchin Maintained (ALGT) at Hold with Decreased Target to $170 on, Apr 12th, 2017

Tue, April 11, 2017

by: WOPRAI

BYFC SqueezeTrigger Price is $1.73. There is $4,296 That Short Sellers Still Need To Cover.

by: WOPRAI

ACNB Corporation (NASDAQ:ACNB), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Report

by: WOPRAI

Vectren Corp (NYSE:VVC), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Report

by: WOPRAI

Peoples Financial Corporation (NASDAQ:PFBX), Up By $0.78 (5.90%) After BUYINS.NET SqueezeTrigger Report Released on Monday, Apr

by: WOPRAI

Ophthotech Corporation (NASDAQ:OPHT), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In

by: WOPRAI

NTIC SqueezeTrigger Price is $15.19. There is $39,600 That Short Sellers Still Need To Cover.

by: WOPRAI

GILT SqueezeTrigger Price is $4.79. There is $25,239 That Short Sellers Still Need To Cover.

by: WOPRAI

Premium Brands Holdings Corp (NYSE:PBH), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In O

by: WOPRAI

Transdigm Group Incorporated (NYSE:TDG), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In O

by: WOPRAI

Concord Medical Services Holdings Limited (NYSE:CCM), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditi

by: WOPRAI

Epizyme Inc. (NASDAQ:EPZM), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Report

by: WOPRAI

Barclays Bank iPath Exch Traded Nts 2009-30.1.19 iPath S&P 500 VIX Short Term Futures Ser A (NYSE:VXX), Up After BUYINS.NET Rep

by: WOPRAI

Achillion Pharmaceuticals Inc. (NASDAQ:ACHN), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outl

by: WOPRAI

Ambarella Inc. (NASDAQ:AMBA), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Repo

by: WOPRAI

Electromed Inc. (NYSE:ELMD), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Repor

by: WOPRAI

MSL SqueezeTrigger Price is $14.05. There is $4,942,910 That Short Sellers Still Need To Cover.

by: WOPRAI

BCH SqueezeTrigger Price is $73.26. There is $2,796,963 That Short Sellers Still Need To Cover.

by: WOPRAI

PEX SqueezeTrigger Price is $39.72. There is $76,836 That Short Sellers Still Need To Cover.

by: WOPRAI

TATT SqueezeTrigger Price is $6.80. There is $60,760 That Short Sellers Still Need To Cover.

by: WOPRAI

Richardson Electronics, Ltd. (NASDAQ:RELL) Up By 6.78% ($0.39) From $5.750 After BUYINS.NET Report Predicted Strength After Ear

by: WOPRAI

Seadrill Limited (NYSE:SDRL), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Report

by: WOPRAI

Nektar Therapeutics (NASDAQ:NKTR), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our

by: WOPRAI

Kopin Corporation (NASDAQ:KOPN), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our R

by: WOPRAI

U.S. Stem Cell Inc. (OTC:USRM), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Re

Derek Archila Initiated (VNDA) at Buy on, Apr 12th, 2017

Derek Archila of Oppenheimer, Initiated "Vanda Pharmaceuticals Inc." (VNDA) at Buy on, Apr 12th, 2017.

Derek, nor any peers, have made any analyst calls on VNDA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30